|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
11.300 -0.210 (-1.825%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 2,013,530 | 1,391,132 | 151,048 | 1,354,099 |
| Net Cash from / (used in) Investing Activities | -- | (1,330,672) | (1,072,703) | 1,087,807 | 68,306 |
| Net Cash from / (used in) Financing Activities | -- | 894,387 | (376,563) | (894,834) | (753,681) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 1,577,245 | (58,134) | 344,021 | 668,724 |
| Cash & Cash Equivalents at beginning of period | -- | 1,952,586 | 2,008,434 | 1,658,312 | 974,464 |
| Effect of Foreign Exchange Rate Changes | -- | (17,743) | 2,286 | 4,829 | 15,124 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 3,512,088 | 1,952,586 | 2,007,162 | 1,658,312 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 828,720 |
| %Change | 37.878% |
| EPS / (LPS) | RMB 0.320 |
| NBV Per Share (¥) | RMB 3.670 |